Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma.
Ananthapadmanabhan V, Frost TC, Soroko KM, Knott A, Magliozzi BJ, Gokhale PC, Tirunagaru VG, Doebele RC, DeCaprio JA
JCI Insight. 2022 Jul 8;7(13). pii: 160513. doi: 10.1172/jci.insight.160513.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.